Author:
Freedman Barry I.,Murea Mariana
Publisher
Springer Science and Business Media LLC
Reference75 articles.
1. U.S. Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, MD. 121–132. 2010.
2. Kiberd BA, Clase CM. Cumulative risk for developing end-stage renal disease in the US population. J Am Soc Nephrol. 2002;13:1635–44.
3. McClellan WM, Newsome BB, McClure LA, et al. Poverty and racial disparities in kidney disease: the REGARDS study. Am J Nephrol. 2010;32:38–46.
4. Evans K, Coresh J, Bash LD, et al. Race differences in access to health care and disparities in incident chronic kidney disease in the US. Nephrol Dial Transplant. 2011;26:899–908.
5. •• Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010, 329:841–845. This landmark report revealed that two coding variants in the apolipoprotein L1 gene (APOL1), termed G1 and G2, were strongly associated with FSGS and nondiabetic forms of ESRD. These diseases were previously attributed to variation in the adjacent non-muscle myosin heavy chain 9 gene (MYH9). The protein product of nephropathy-associated APOL1 variants lysed Trypanosoma brucei rhodesiense, a cause of African sleeping sickness.
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献